MITF and neoplasm: This analysis revealed a loss of the immune-related molecule CCL2 over time, contributing to a “cold” tumor microenvironment, and an increase in metastasis-associated molecules like MITF, KIT, and VIM, suggesting a potential transition to a mesenchymal phenotype.